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ABSTRACT 
An indium-mediated isomerization of 1,4-dienols to 1,3-dienols is described. This 
procedure consists of the addition of pentadienylindium, in a protic solvent, to 
aldehydes giving the kinetic γ-allylation product in high yields. The subsequent 
conversion of this γ-allylation product to its thermodynamic 1,3-dienol α-isomer can 
be achieved by its exposure to indium triflate in the presence of a sub-stoichiometric 
amount of aldehyde at room temperature. This transformation exhibited moderate to 
good substrate scope and has been shown to proceed by a 2-oxonia Cope 
rearrangement. 
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INTRODUCTION 
1,4-Dienol motifs (1) are a valuable and sought after precursors in organic synthesis 
due to their unique functional connectivity. 1,4-Dienols 1 can undergo elimination 
reactions to give trienes such as 2 that have been shown to be excellent Diels-Alder 
platforms (scheme 1), therefore enabling significant molecular complexity to be built 
up quickly in very few synthetic transformations.1 The connectivity of 1,4-dienols (1) 
has been harnessed in ruthenium catalyzed RCM transformation delivering unique 
cyclic and polycyclic structures.2 Furthermore, 1,4-dienol 1 can undergo facile 
isomerization to the thermodynamically favored α-allylic alcohol product 3 (1,3-
dienol) that is central to numerous natural products of biological importance as well 
as useful synthetic intermediates (Scheme 1).3 
 
Scheme 1. Synthetic utility of 1,4-dienols and their conversion to 1,3-dienols. 
The resolvin D- and E-series (Scheme 2, e.g. resolving D1 and resolving E1) are a 
class of metabolites derived from the ω-3 fatty acids, docosahexaenoic acid (DHA) 
and eicosapentaenoic acid (EPA). They have been implicated in the regulation of 
human diseases linked to chronic inflammation such as cardiovascular disease, 
asthma and rheumatoid arthritis.4a-c In a project looking at the biological importance 
of these fatty acids metabolites4d we required access to a range of racemic 1,3-
dienols with aryl, alkenyl and alkynyl substitution that mirrored that within the resolvin 
D1 and E1 structures (scheme 2, 4-6). We envisaged that 1,3-dienols of this type 
could be accessed via a 2-oxonia Cope rearrangement of a 1,4-dienol, which in turn 
could be accessed from an appropriate aldehyde (9) and a pentadienyl equivalent 
(scheme 2). This approach was based on two benchmarks (a) the ability to easily 
synthesize the 1,4-dienol precursors; and (b) literature precedent for the 
thermodynamic rearrangement to the required 1,3-dienols. 
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Scheme 2. Targeted 1,3-dienols using a 2-oxonia Cope rearrangement. 
Firstly, within the literature there are several robust synthetic methods for the 
synthesis of the 1,4-dienol precursors (10), all of which are based on the addition of 
a pentadienyl equivalent to a carbonyl substrate 9 (scheme 2). These include the 
Lewis acid mediated addition of 2,4-pentadienyltrimethylsilane,5-7 and 
pentadienyltrimethylstannane2d,8 to an aldehyde. Pentadienylzincates9 and penta-
2,4-dienyltitanium complexes10 have also been successfully added to carbonyls; and 
the direct addition of a 1,4-pentadienyl equivalent via treatment with strong base,11 
has also been successfully employed. An alternate and more environmentally 
applicable approach has been the addition of pentadienylindium, generated from 
indium metal and pentadienylbromide, to the requisite carbonyl. Indium has become 
an important metal in a range Barbier type additions to carbonyls due to its functional 
group tolerance and low toxicity.12,13 Secondly, the 2-oxonia Cope rearrangements 
are not unprecedented when performed on 1,4-dienols (scheme 2); Nokami3a and 
co-workers demonstrated that 1,4-dienol 7 undergoes a diastereoselective, acid 
catalyzed, 2-oxonia Cope rearrangement to give its α-product 8, in high enantiomeric 
excess; however, this report was limited to only three aliphatic examples. Therefore, 
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we would like to disclose our results on using this 2-oxonia Cope rearrangement to 
the synthesise 1,3-dienols with aryl, alkenyl and alkynyl substitutions. 
RESULTS AND DISCUSSION 
The target compounds for our study necessitated the selection of aldehyde 12 as the 
starting point. Previous reports had already indicated that DMF, THF and DMSO 
would be ideal solvents for the addition of bromide 13, as they all gave the required 
γ-addition product. However, in a desire to use more environmentally benign 
solvents, H2O was selected as the starting point, previously used only by Fallis within 
the context of bromide 13 and a small subset of aldehydes and ketones.1f,3b 
Consequently, when aldehyde 12 was exposed to 13, indium (1.5 equiv.) and H2O, it 
was gratifying to isolate the desired γ-addition product 14 in 51% isolated yield 
(scheme 3). This modest yield and significant amount of unreacted starting material 
in the crude 1H NMR led us to question the solubility of starting material 12 in H2O as 
solvent. To address this a 3:1 mixture of ethanol14 and water was trialed leading to a 
welcomed increase isolated yield of 67% confirming our speculation. Finally, further 
increase in isolated yield to 81% was obtained when absolute ethanol was used.  
 
Scheme 3. Indium mediated addition of bromide 13 to aldehyde 12 in H2O, ethanol 
and mixtures thereof. 
With optimized conditions in hand, we then examined these conditions on range of 
aryl, alkenyl and alkynyl aldehydes that were appropriate for our study (scheme 4).  
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Scheme 4. Synthesis of 1,4-dienols. 
Benzaldehyde and 2-, 3-, and 4-bromobenzaldehyde gave the expected 1,4-dieneol 
products (15-18) in good to excellent yields of 71-92%; however, p-anisaldehyde 
yielded its addition product 19 in a very poor isolated yield of only 5%, due likely to 
the deactivation of the electrophile by the methoxy group. An increase in steric bulk 
was accommodated as indicated by the successful conversion of α-naphthaldehyde 
giving its addition product 20 in 86% isolated yield. Acetophenone also underwent 
smooth addition to give the γ-addition product 21a in 76%; however, within the crude 
1H NMR, a small trace amount of the α-addition product 22b could be identified, 
possibly due to the increase in steric bulk of the electrophile. Cinnamaldehyde gave 
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its addition product 22 in 60% isolated yield, and both linear and branched aliphatic 
aldehydes gave the desired 1,4-dienols in good to high yields giving 23 and 24 in 
76% and 69% yields, respectively. The alkynyl aldehyde 12, crucial to our own 
work,4d could also be scaled up to 12 mmol, giving the addition product 14 in an 
isolated yield of 80%. We also found that glycoaldehyde dimer 26 could be utilized in 
this process giving access to the diol 25 in 72% isolated yield. 
The isomerization of the 1,4-dienols to the desired 1,3-dienols was optimized using 
substrate 15 (scheme 5 and table 1). 
Scheme 5 and table 1. Optimization experiments for the conversion of 1,4-dienol 15 
to its respective conjugated species 27.a 
 
entry Lewis Acidb 
Benzaldehyde 
(mol%) 
Temp. (°C) Yield 27 [%]c 
1 - - rt - 
2 - - 40 - 
3 In(OTf)3 - rt 23 
4 AlCl3 - rt 22 
5 Sn(OTf)2 - rt 23 
6 In(OTf)3 10 rt 67 
7 In(OTf)3 20 rt 65 
8 In(OTf)3 50 rt 67 
9 In(OTf)3 100 rt 67 
10 - 10 rt - 
11 In(OTf)3 10 40 63 
12 In(OTf)3 - 40 19 
13d In(OTf)3 10 rt 66 
aReactions were performed in CH2Cl2 under N2 atmosphere at 0.5M for 24h unless otherwise 
stated. b10 mol% of Lewis acid. cIsolated yields in all cases. d48h reaction time. 
OH OH
15 27
see table 1
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Initially, we found that simple heating of 15 did not yield the desired 1,3-dienol but 
simply returned starting material (entries 1 and 2). We then investigated the use of a 
Lewis acid catalyst to effect the rearrangement of 15 to 27 and found that In(OTf)3,15a 
Sn(OTf)2, and AlCl3, all at room temperature, achieved the rearrangement, but in 
poor isolated yields (entries 3-5).16 It must be noted that 27 was isolated in a E:Z 
ratio of approx. 9:1, in favor of the E-stereoisomer, in each case. With these 
promising results in hand, we next examined the addition of benzaldehyde in an 
effort to promote the 2-oxonia Cope rearrangement.3a,15b,c Accordingly, upon the 
addition of 10 mol% of benzaldehyde, in the presence of In(OTf)3 we isolated the 
desired 1,3-diene-ol 27 in a dramatically improved yield of 67% (entry 6). A screen in 
the amount of benzaldehyde was then examined but no discernible increase in 
isolated yields was observed (entries 7-9). A control experiment in the absence of 
Lewis acid, but in the presence of 10 mol% of benzaldehyde, confirmed the crucial 
role of the Lewis acid in this rearrangement (entry 10). An increase in reaction 
temperature had no significant effect on the isolated product yield of 27 (entry 11); 
and when this elevated temperature attempt was performed in the absence of 
benzaldehyde (entry 12) the result mirrored that in entry 3. Finally, extending the 
reaction time had no noticeable effect in the isolated yield of 27 (entry 13). 
With conditions for the 2-oxonia Cope rearrangement of 1,4-dienol 15 to 27 now 
identified, the scope of this reaction process was examined using the 1,4-dienols 
from scheme 4 (scheme 6). 
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Scheme 6. Synthesis of 1,3-dienols. 
This process was met with moderate success. The 2-, 3-, and 4-bromoaryl 
analogues were all rearranged to the target 1,3-diene-ol in good isolated yields 
giving 28, 29 and 30, respectively. The α-naphthyl analogue participated in the 
rearrangement giving the thermodynamic product 32 in good yield, and the 
rearrangement was tolerant of alkyl substitution as exemplified by the cyclohexyl 34 
and isovaleryl 35 examples. The aryl 1,4-diene 15 could be rearranged at an 
increased scale of 5 mmol giving the 1,3-diene 27 in comparable chemical yield. 
Finally, the TMS protected alkynyl-1,4-diene 14 was converted to its 1,3-diene 
isomer 36 in a good yield, and pleasingly this gave a valuable building block that 
could be potentially used in further work towards the synthesis of the resolvins and 
other marine derived fatty acids. Unfortunately, the 4-methoxyaryl (22), pent-4-en-2-
ol (21a),  cinnammyl (22) and 1,2-diol 25 precursors, gave little or none of the desired 
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products (31, 33, 21b and 37, respectively), as well as yielding complex mixtures of 
products as identified by NMR in each case. With regard to the E/Z stereoisomer 
ratio, the majority of the aryl derivatives were obtained in a ratio in-line with the 
parent phenyl analogue, i.e. E/Z ratio of approx. 9:1. However, the 2-bromophenyl 
derivative, 30, was obtained as the E-isomer exclusively, with none of its Z-isomer 
observed in the 1H NMR spectra. In contrast, the cyclohexyl (30) and isovaleryl (31) 
analogues were obtained in E/Z ratios of 3:2 and 3:1, respectively. 
The 1,3-dienol 37 derived from 1,2-diol 25 would have contained a useful synthetic 
handle; however, its failure to participate in the rearrangement could be mitigated as 
shown below in scheme 7. Treatment of 15 with ethyl propiolate gave the enol ester 
38, that when treated with TFA gave the thermodynamic diene 39 in 82% in an E/Z 
ratio of 94:6, and with a 1,3-diene with a useful synthetic handle for further 
manipulation. 
 
Scheme 7. Acid catalyzed rearrangement of 1,2-diol 38. 
Mechanistically the 2-oxonia Cope rearrangement follows the reports previously 
published (scheme 5).3,15 Firstly, Lewis acid activation of benzaldehyde promotes 
formation of the oxocarbenium ion 41 via 40. This oxocarbenium ion 41 then 
undergoes a 2-oxonia Cope rearrangement to deliver the thermodynamic product 42, 
with none of the Prins cyclisation product 43 being detected or isolated. It is 
assumed15,17 that the 2-oxonia Cope rearrangement goes via the corresponding 
chair transition states. The dominant stereoisomer in each rearrangement was of E-
stereochemistry, however in some cases a small amount of the Z-stereoisomer could 
be detected by 1H NMR spectroscopy, and this presumably occurs via bond rotation 
between C2-C3 within 41 as shown by 41a and 41aa (scheme 7). 
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Scheme 7. Mechanism for the kinetic to thermodynamic isomerization using 
In(OTf)3. 
CONCLUSIONS 
In summary, we have reported a two-step process for the synthesis of 1,3-dienols. A 
2-oxonia Cope rearrangement was utilized to rearrange 1,4-dienols to their 
thermodynamic 1,3-dienol products, and this was facilitated by Lewis acid catalysis 
with a sub-stoichiometric amount of the requisite aldehyde. This process has modest 
substrate scope, but unfortunately failed with cinnamyl-substituted systems. 
However, it was demonstrated to be tolerant of alkynes, which in the context of our 
research programme should provide a suitable synthetic building for synthesizing 
fatty acid analogues. 
EXPERIMENTAL PROCEDURES 
General procedure for indium addition with (E)-5-bromopenta-1,3-diene. 
Aldehyde or ketone (1.00 mmol) and (E)-5-bromopenta-1,3-diene 13 (1.20 mmol) 
were added to absolute ethanol (6 mL) and allowed to stir at room temperature.  
Indium powder (1.50 mmol) was added slowly, so as not to increase the temperature 
of the reaction mixture, and then allowed to stir at room temperature for 72 h. The 
reaction mixture was diluted with diethyl ether and then filtered through a plug of 
silica.  The solvent was then removed by evaporation under reduced pressure and 
the crude product purified by column chromatography. 
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1-Phenyl-2-vinylbut-3-en-1-ol (15).8d The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a colorless 
liquid (157 mg, 0.90 mmol, 92%): 1H NMR (CDCl3, 400MHz): δ 7.41 - 7.28 (m, 5H), 
5.88 (ddd, J = 17.2, 10.4, 8.2 Hz, 1H), 5.71 (ddd, J = 17.2, 10.4, 7.2 Hz, 1H), 5.26 
(dt, J = 9.6, 0.8 Hz, 1H), 5.22 (dt, J = 16.0, 1.2 Hz, 1H), 5.07 (dt, J = 10.4, 1.2 Hz, 
1H), 5.04 (dt, J = 17.2, 1.2 Hz, 1H), 4.61 (dd, J = 6.8, 2.0 Hz, 1H), 3.13 (dq, J = 7.2, 
0.8 Hz, 1H), 2.27 (br s, 1H); 13C NMR (CDCl3, 100MHz) δ 140.8, 135.8, 135.7, 
127.1, 126.9, 125.7, 117.4, 116.1, 75.2, 55.2; IR (NaCl): 3079, 3066, 1634, 1603 cm–
1; HRMS (ESI): m/z [M+H] + calcd for C12H14O: 175.1123, found: 175.1126. 
1-(2-Bromophenyl)-2-vinylbut-3-en-1-ol (16). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a 
colorless liquid (225 mg, 0.89 mmol, 89%): 1H NMR (CDCl3, 400MHz) δ 7.50 (dd, J = 
8.0, 1.2 Hz, 1H), 7.46 (d, J = 7.6 Hz, 1H), 7.31 (t, J = 15.2 Hz, 1H), 7.11 (dt, J = 7.6, 
2.0 Hz, 1H), 5.95 - 5.83 (m, 2H), 5.21 - 5.01 (m, 5H), 3.20 (q, J = 6.8 Hz, 1H), 2.25 
(s, 1H); 13C NMR (CDCl3, 100MHz) δ 141.1, 137.1, 135.6, 132.7, 128.9, 129.6, 
127.7, 122.6, 118.6, 117.0, 74.5, 54.5; IR (NaCl): 3427, 3077, 1636, 619 cm–1; 
HRMS (ESI): m/z [M+H]+ calcd for C12H12O79Br: 251.0066, found: 251.0068. 
1-(3-Bromophenyl)-2-vinylbut-3-en-1-ol (17). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a 
colorless liquid (180 mg, 0.71 mmol, 71%): 1H NMR (CDCl3, 400MHz) δ 7.51 - 7.49 
(m, 1H), 7.41 (dt, J = 6.8, 2.0 Hz, 1H), 7.26 - 7.19 (m, 2H), 5.83 (ddd, J = 17.2, 10.4, 
8.0 Hz, 1H), 5.69 (ddd, J = 17.6, 10.4, 7.2 Hz, 1H), 5.27 (ddd, J = 10.4, 1.6, 0.8 Hz, 
1H), 5.18 (dd, J = 17.2, 1.6, 0.8 Hz, 1H), 5.10 (dt, J = 10.4. 1.2 Hz, 1H), 5.04 (dt, J = 
17.2, 1.2 Hz, 1H), 4.56 (d, J = 6.8 Hz, 1H), 3.07 (q, J = 7.2 Hz, 1H), 2.40 (bs, 1H); 
13C NMR (CDCl3, 100MHz) δ 144.2, 136.3, 136.2, 130.7, 129.9, 129.7, 125.6, 118.8, 
117.6, 122.3, 75.5, 56.2; IR (NaCl): 3400, 3084, 1637, 739 cm–1; HRMS (ESI): m/z 
[M+H]+ calcd for C12H12O79Br: 251.0066, found: 251.0058. 
1-(4-Bromophenyl)-2-vinylbut-3-en-1-ol (18).1a The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a 
colorless liquid (228 mg, 0.90 mmol, 90%): 1H NMR (CDCl3, 400MHz) δ 7.44 (d, J = 
8.0 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 5.80 (ddd, J = 18.0, 10.8, 8.4 Hz, 1H), 5.64 
(ddd, J = 17.6, 10.8, 7.2 Hz, 1H), 5.25 - 5.13 (m, 2H), 5.07 - 4.97 (m, 2H), 4.54 (dd, J 
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= 7.2, 3.2 Hz, 1H), 3.03 (q, J = 7.6 Hz, 1H), 2.24 (d, J = 3.2 Hz, 1H); 13C NMR 
(CDCl3, 100MHz) δ 140.8, 136.4, 136.3, 131.2, 128.6, 121.5, 118.8, 117.6, 75.5, 
56.3; IR (NaCl): 3420, 3079, 1635, 623 cm–1; HRMS (ESI): m/z [M+H]+ calcd for 
C12H12O79Br: 251.0066, found: 251.0068. 
1-(4-Methoxyphenyl)-2-vinylbut-3-en-1-ol (19).9b The title compound was isolated 
by column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a 
dark yellow liquid (11 mg, 0.05 mmol, 5%): 1H NMR (CDCl3, 400MHz) δ 7.22 (d, J = 
8.0 Hz, 2H), 6.86 (d, J = 7.6 Hz, 2H), 5.84 (dt, J = 16.8, 9.2 Hz, 1H), 5.64 (dt, J = 
16.8, 8.0 Hz, 1H), 5.21 (dd, J = 16.4, 10.0 Hz, 2H), 5.01 (t, J = 10.4 Hz, 2H), 4.52 (d, 
J = 7.2 Hz, 1H), 3.79 (s, 3H), 3.07 (q, J = 7.6 Hz, 1H), 2.16 (bs, 1H); 13C NMR 
(CDCl3, 100MHz) δ 159.1, 137.1, 136.8, 134.0, 128.1, 118.3, 117.0, 113.6 (x2), 75.8, 
56.3, 55.3; IR (NaCl): 3419 (br), 1634, 1219 cm–1; HRMS (ESI): m/z [M+Na]+ calcd 
for C13H16O: 227.1048, found: 227.1037. 
1(1-Naphthyl)-2-vinylbut-3-en-1-ol (20). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a 
colorless liquid (192 mg, 0.86 mmol, 86%): 1H NMR (CDCl3, 400MHz) δ 8.08 (d, J = 
8.0 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.60 (d, J = 7.2 Hz, 
1H), 7.53 - 7.45 (m, 4H), 5.96 - 5.81 (m, 2H), 5.45 (dd, J = 6.0, 3.6 Hz, 1H), 5.22 (dd, 
J = 10.4, 0.8 Hz, 1H), 5.12 - 5.03 (m, 3H), 3.41 - 3.38 (m, 1H), 2.22 (d, J = 3.6 Hz, 
1H); 13C NMR (CDCl3, 100MHz) δ 137.8, 137.6, 136.3, 133.9, 130.7, 129.1, 128.2, 
126.1, 125.5, 125.3, 124.5, 123.3, 118.6, 116.8, 72.9, 54.8; IR (NaCl): 3583, 3084, 
1677, 1421, 1265 cm–1; HRMS (ESI): m/z [M+Na]+ calcd for C16H16O: 247.1099, 
found: 247.1083. 
2-Phenylpent-4-en-2-ol (21a).8d The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a colorless 
liquid (142 mg, 0.76 mmol, 76%): 1H NMR (CDCl3, 400MHz) δ 7.44 - 7.41 (m, 2H), 
7.38 - 7.33 (m, 2H), 7.28 - 7.24 (m, 1H), 5.81 (ddd, J = 17.2, 10.4, 8.8 Hz, 1H), 5.74 
(ddd, J = 17.6, 10.4, 7.2 Hz, 1H), 5.20 (ddd, J = 10.4, 1.6, 0.4  Hz, 1H), 5.16 - 5.13 
(m, 1H), 5.14 - 5.09 (m, 2H), 3.15 (t, J = 7.6 Hz, 1H), 2.17 (s, 1H), 1.57 (s, 3H); 13C 
NMR (CDCl3, 100MHz) δ 146.4, 136.8, 136.3, 127.9, 126.7, 125.5, 118.1, 75.3, 29.8, 
27.6; HRMS (ESI): m/z [M+Na]+ calcd for C13H16O: 211.1099, found: 211.1087. 
	   14	  
1-(Cinnamyl)-2-vinylbut-3-en-1-ol (22).6b The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a dark 
yellow liquid (120 mg, 0.60 mmol, 60%): 1H NMR (CDCl3, 400MHz) δ 7.46 – 7.41 (m, 
2H), 7.38 – 7.34 (m, 2H), 7.31 – 7.26 (m, 1H), 6.65 (dd, J = 16.0, 0.8 Hz, 1H), 6.27 
(dd, J = 16.0, 6.4 Hz, 1H), 5.97 - 5.88 (m, 1H), 5.92 – 5.86 (m, 1H), 5.29 - 5.19 (m, 
4H), 4.30 (t, J = 6.0 Hz, 1H), 3.08 - 3.02 (tq, J = 7.2, 1.2 Hz, 1H), 2.12 (bs, 1H); 13C 
NMR (CDCl3, 100MHz) δ 136.8, 136.6, 131.6, 129.7, 128.6, 127.7, 126.6, 118.0, 
117.7, 76.8, 55.0; IR (NaCl): 3400, 3061, 1636 cm–1; HRMS (ESI): m/z [M+H]+ calcd 
for C14H16O: 201.1279, found: 201.1273. 
1-Cyclohexyl-2-vinylbut-3-en-1-ol (23).8d The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.5) yielding a 
colorless liquid (137 mg, 0.76 mmol, 76%): 1H NMR (CDCl3, 400MHz) δ 5.85 (ddd, J 
= 16.4, 10.0, 8.4 Hz, 1H), 5.85 - 5.77 (m, 1H), 5.17 (dd, J = 10.0, 1.6 Hz, 1H), 5.12 
(ddd, J = 10.8, 2.0, 1.2 Hz, 1H), 5.12 – 5.10 (m, 1H), 5.09 – 5.07 (m, 1H), 3.29 - 3.25 
(m, 1H), 2.95 (q, J = 7.2 Hz, 1H), 1,88 - 1.79 (m, 1H), 1.78 - 1.69 (m, 2H), 1.68 - 1.57 
(m, 2H), 1.48 - 1.37 (m, 1H), 1.29 - 1.00 (m, 5H); 13C NMR (CDCl3, 100MHz) δ 
136.5, 135.3, 115.4, 114.2, 75.3, 49.7, 38.4, 27.9, 24.9, 24.5, 24.4, 24.2; IR (NaCl): 
3435 (br), 3077, 1633 cm–1; HRMS (ESI): m/z [M+Na]+ calcd for C12H20O: 203.1412, 
found: 203.1406. 
6-Methyl-3-vinylhept-1-en-4-ol (24).18 The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a colorless 
liquid (106 mg, 0.69 mmol, 69%): 1H NMR (CDCl3, 400MHz) δ 5.86 (ddd, J = 10.0, 
8.0, 4.8 Hz, 1H), 5.81 (ddd, J = 12.8, 7.6, 4.4 Hz , 1H), 5.21 (dd, J = 10.4, 1.2 Hz, 
1H), 5.18 – 5.15 (m, 1H), 5.16 – 5.14 (m. 1H), 5.13 (ddd, J = 5.6, 2.4, 0.8 Hz, 1H), 
3.65 (dt, J = 9.6, 4.4 Hz, 1H), 2.79 (q, J = 7.6 Hz, 1H), 1.89 - 1.79 (m, 1H), 1.65 (d, J 
= 4.4 Hz, 1H), 1.36 - 1.29 (m, 2H), 0.95 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H); 
13C NMR (CDCl3, 100MHz) δ 137.6, 136.9, 117.6, 116.9, 71.2, 55.4, 43.4, 24.6, 23.8, 
21.7; IR (NaCl): 3368 (br), 3079, 1635 cm–1; HRMS (ESI): m/z [M+H]+ calcd for 
C10H18O: 155.1436, found: 155.1429. 
3-Vinylpent-4-ene-1,2-diol (25). The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.2) yielding a colorless oil 
(92 mg, 0.72 mmol, 72%): 1H NMR (CDCl3, 400MHz) δ 5.86 (ddd, J = 16.8. 10.8, 8.0 
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Hz, 1H), 5.77 (ddd, J = 16.8, 10.8, 8.0 Hz, 1H), 5.21 - 5.16 (m, 2H), 5.15 – 5.11 (m, 
2H), 3.71 - 3.62 (m, 2H), 3.55 - 3.47 (m, 1H), 3.23 (bs, 1H), 3.15 (m, 1H), 2.88 (q, J = 
8.0 Hz, 1H); 13C NMR (CDCl3, 100MHz) δ 136.8, 136.7, 117.5, 117.1, 73.6, 64.6, 
51.7; IR (NaCl): 3365 (br), 3003, 1637 cm–1; HRMS (ESI): m/z [M+Na]+ calcd for 
C7H12O2: 151.0735, found: 151.0729. 
1-(Trimethylsilyl)-4-vinylhex-5-en-1-yn-3-ol (14). Aldehyde 12 (1.51 g, 12.00 
mmol) and (E)-5-bromopenta-1,3-diene 13 (2.12 g, 14.40 mmol) were added to 
absolute ethanol (20 mL) and allowed to stir at room temperature.  Indium powder 
(2.05 g, 18.00 mmol) was added in portions, so as not to increase the temperature of 
the reaction mixture, and then allowed to stir at room temperature for 72 h. The 
reaction mixture was diluted with diethyl ether and then filtered through a plug of 
silica.  The solvent was then removed by evaporation under reduced pressure and 
the crude product purified by column chromatography. The title compound was 
isolated by column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.6) 
yielding a pale yellow oil (1.87 g, 9.60 mmol, 80%): 1H NMR (CDCl3, 400MHz) δ 5.91 
(ddd, J = 17.2, 10.4, 8.0 Hz, 2H), 5.28 - 5.18 (m, 4H), 4.33 (dd, J = 7.2, 5.6 Hz, 1H), 
3.07 - 3.02 (m, 1H), 2.10 (d, J = 7.2 Hz, 1H), 0.19 (s, 9H); 13C NMR (CDCl3, 
100MHz) δ 136.1, 135.7, 118.7, 118.2, 104.6, 91.2, 65.3, 54.7, 0.01; IR (NaCl): 3429 
(br), 3008, 2173, 1638 cm–1; HRMS (ESI): m/z [M+Na]+ calcd for C11H18OSi: 
217.1019, found: 217.1020. 
General procedure for the rearrangement from branched to straight chain 
diene 
Branched chain diene (1.0 mmol) in dichloromethane (2.0 mL / mmol) was added to 
indium trifluoromethanesulfonate (10 mol %) and the aldehyde (10 mol %) and 
allowed to stir at room temperature for 24 h.  The reaction mixture was then 
transferred to a separating funnel, diluted with further dichloromethane and washed 
with distilled water.  The organic extracts were retained, dried (Na2SO4), filtered and 
the solvent removed by evaporation under reduced pressure.  The title compound 
was isolated by column chromatography. The following compounds were 
synthesized using this method. 
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(E)-1-Phenylhexa-3,5-dien-1-ol (27). The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a colorless 
liquid (116 mg, 0.67 mmol, 67%): 1H NMR (400MHz, CDCl3) δ 7.42 - 7.29 (m, 5H), 
6.35 (td, J = 16.8 ,10.0 Hz, 1H), 6.22 (dd, J = 15.2, 10.4 Hz, 1H), 5.71 (dt, J = 15.2, 
7.2 Hz, 1H), 5.18 (d, J = 16.4 Hz, 1H), 5.06 (d, J = 10.0 Hz, 1H), 4.80 - 4.74 (m, 1H), 
2.60 - 2.56 (m, 2H), 2.13 (d, J = 3.2 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 143.9, 
136.8, 134.4, 130.1, 128.5, 127.7, 125.8, 116.3, 73.7, 42.6; IR (NaCl): 3411, 3080, 
3030, 1634, 1603 cm-1; HRMS (ESI): m/z [M-H+] calcd for C12H13O: 173.0966, found: 
173.0961. 
(E)-1-(2-Bromophenyl)hexa-3,5-dien-1-ol (28). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a 
colorless liquid 182 mg, 0.72 mmol, 71%): 1H NMR (400MHz, CDCl3) δ 7.82 (d, J = 
7.6 Hz, 1H), 7.64 (dd, J = 8.0, 1.2 Hz, 1H), 7.18 - 7.08 (m, 2H), 6.07 (d, J = 1.2 Hz, 
1H), 5.95 - 5.84 (m, 1H), 5.71 (dd, J = 16.0, 5.6 Hz, 1H), 5.29 (dd, J = 5.6, 2.4 Hz, 
1H), 4.58 (dd, J = 10.8, 5.6 Hz, 1H), 2.64 - 2.53 (m, 1H), 2.39 - 2.28 (m, 1H); 13C 
NMR (100MHz, CDCl3) δ 142.7, 133.1, 132.7, 132.6, 130.5, 128.5, 121.2, 100.6, 
78.0, 77.2, 72.1, 40.6; IR (NaCl) 3428, 3077, 1636, 619 cm-1; HRMS (ESI): m/z [M-
H+] calcd for C12H12O79Br: 251.0072, found: 251.0065. 
(E)-1-(3-Bromophenyl)hexa-3,5-dien-1-ol (29). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a 
colorless liquid (175 mg, 0.69 mmol, 69%): 1H NMR (400MHz, CDCl3) δ 7.57 - 7.54 
(m, 1H), 7.45 - 7.41 (m, 1H), 7.31 - 7.22 (m, 2H), 6.34 (td, J = 16.8, 10.0 Hz, 1H), 
6.20 (dd, J = 15.2, 10.4 Hz, 1H), 5.68 (dt, J = 15.2, 7.6 Hz, 1H), 5.19 (d, J = 16.8 Hz, 
1H), 5.08 (d, J = 10.0 Hz, 1H), 4.75 - 4.71 (m, 1H), 2.59 - 2.46 (m, 2H), 2.11 (d, J = 
3.2 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 146.2, 136.6, 134.9, 132.8, 130.6, 130.0, 
129.4, 124.4, 122.6, 116.7, 72.9, 42.7; IR (NaCl) 3391, 3084, 1637, 704 cm-1; HRMS 
(ESI): m/z [M-H+] calcd for C12H12O79Br: 251.0072, found: 251.0059. 
(E)-1-(4-Bromophenyl)hexa-3,5-dien-1-ol (30). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a 
colorless liquid (180 mg, 0.71 mmol, 72%): 1H NMR (400MHz, CDCl3) δ 7.46 (d, J = 
8.0 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.30 (td, J = 16.8, 10.8 Hz, 1H), 6.15 (dd, J = 
15.6, 10.4 Hz, 1H), 5.63 (dt, J = 14.4, 8.0 Hz, 1H), 5.15 (dd, J = 16.8, 7.6 Hz, 1H), 
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5.07 - 5.01 (m, 1H), 4.74 - 4.66 (m, 1H), 2.55 - 2.43 (m, 2H), 2.00 (d, J = 3.2 Hz, 1H); 
13C NMR (100MHz, CDCl3) δ 142.8. 136.6, 134.9, 131.6, 129.4, 127.6 (x2), 121.4, 
116.6, 70.0, 42.7; IR (NaCl) 3419, 3079, 1635, 623 cm-1; HRMS (ESI): m/z [M-H+] 
calcd for C12H12O79Br: 251.0072, found: 251.0066. 
 (E)-1-(1-Naphthyl)hexa-3,5-dien-1-ol (14) (32). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.3) yielding a 
colorless liquid (152 mg, 0.68 mmol, 72%): 1H NMR (400MHz, CDCl3) δ 8.06 (d, J = 
8.8 Hz, 1H), 7.88 - 7.86 (m, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.66 (d, J = 7.2 Hz, 1H), 
7.65 - 7.46 (m, 3H), 6.34 (dt, J = 16.8, 10.4 Hz, 1H), 6.22 (dd, J = 14.8, 10.4 Hz, 1H), 
5.81 (pent, J = 7.6 Hz, 1H), 5.52 (dd, J = 8.4, 3.2 Hz, 1H), 5.19 - 5.16 (m, 1H), 5.08 - 
5.04 (m, 1H), 2.84 - 2.75 (m, 1H), 2.66 - 2.59 (m, 1H), 2.13 (bs, 1H); 13C NMR 
(100MHz, CDCl3) δ 139.5, 136.8, 134.4, 133.9, 130.5, 130.3, 129.1, 128.1, 126.2, 
125.6, 125.6, 123.0, 122.9, 116.4, 70.5, 41.8; HRMS (ESI) m/z [M+Na+] calcd for 
C16H16O: 247.1099, found: 247.1083. 
(E)-1-Cyclohexylhexa-3,5-dien-1-ol (34). The title compound was isolated by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a 
colorless liquid (108 mg, 0.60 mmol, 60%): 1H NMR (400MHz, CDCl3) δ 6.31 (td, J = 
17.2, 10.4 Hz, 1H), 6.18 - 6.08 (m, 1H), 5.70 (q, J = 8.0 Hz, 1H), 5.11 (d, J = 16.4 Hz, 
2H), 3.42 - 3.34 (m, 1H), 2.38 - 2.29 (m, 2H), 2.22 - 2.13 (m, 1H), 1.40 - 0.98 (m, 
10H); 13C NMR (100MHz, CDCl3) δ 136.9, 134.0, 131.3, 115.8, 75.3, 41.4, 29.9, 
29.7, 26.6, 26.4, 26.3, 22.7; IR (NaCl) 3457, 3088, 2928, 1650 cm-1; HRMS (ESI) 
m/z [M-H+] calcd for C12H19O: 179.1436, found: 179.1429. 
(E)-1-Isovalerylhexa-3,5-dien-1-ol (35). The title compound was isolated by column 
chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.4) yielding a colorless 
liquid (97 mg, 0.63 mmol, 63%): 1H NMR (400MHz, CDCl3) δ 6.31 (dt, J = 16.8, 10.4 
Hz, 1H), 6.12 (dd, J = 15.2, 10.8 Hz, 1H), 5.70 (pent, J = 7.6 Hz, 1H), 5.13 (d, J = 
12.4 Hz, 1H), 5.00 (dd, J = 8.8, 1.2 Hz, 1H), 3.72 - 3.68 (m, 1H), 2.36 - 2.25 (m, 1H), 
2.19 - 2.11 (m, 1H), 1.86 - 1.72 (m, 1H), 1.49 (bs, 1H), 1.42 - 1.36 (m, 1H), 1.27 - 
1.19 (m, 1H), 0.91 - 0.88 (m, 6H); 13C NMR (100MHz, CDCl3) δ 136.9, 134.3, 130.7, 
116.0, 69.2, 46.2, 41.3, 24.7, 26.5, 22.1; IR (NaCl) 3584, 3086, 2927, 1651, 1467, 
1367, 1004 cm-1; HRMS (ESI) m/z [M+Na+] calcd for C10H18O: 177.1255, found: 
177.1241. 
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(E)-1-(Trimethylsilyl)octa-5,7-dien-1-yn-3-ol (36). The title compound was isolated 
by column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.5) yielding a 
pale yellow liquid (110 mg, 0.53 mmol, 53%): 1H NMR (400MHz, CDCl3) δ 6.37 (td, J 
= 16.8, 10.8 Hz, 1H), 6.26 - 6.19 (m, 1H), 5.77 (td, J = 14.8, 7.6 Hz, 1H), 5.19 (dd, J 
= 16.8, 0.8 Hz, 1H), 5.09 (dd, J = 10.4, 1.2 Hz, 1H), 4.43 (q, J = 6.0 Hz, 1H), 2.52 (t, 
J = 6.4 Hz, 2H), 0.18 (s, 9H); 13C NMR (100MHz, CDCl3) δ 137.0, 135.0, 128.5, 
116.5, 105.9, 90.0, 62.2, 40.9, 0.1; IR (NaCl) 3400, 2999, 2152, 1618 cm-1; HRMS 
(ESI) m/z [M+H+] calcd for C11H18OSi: 195.1205, found: 195.1200. 
Ethyl (E)-3-([1-phenyl-2-vinylbut-3-en-1-yl]oxy)acrylate (38) 
To a solution of diene 15 (192 mg, 1.10 mmol) THF (3.00 mL) was added DABCO 
(12 mg, 0.10 mmol) and the resulting solution stirred under N2 and cooled to 0°C. To 
this was added ethyl propiolate (0.10 mL, 1.00 mmol) drop wise over 5 min. and the 
reaction mixture then allowed to warm to room temperature and stirred for overnight. 
The reaction mixture was then concentrated in vacuo and the resultant oil purified by 
column chromatography (4:1, light petroleum: ethyl acetate, Rf = 0.8) yielding a 
colourless liquid (284 mg, 0.95 mmol, 95%): 1H NMR (CDCl3, 400MHz) δ 7.48 (d, J = 
12.8 Hz, 1H), 7.35 - 7.25 (m, 3H), 7.22 - 7.18 (m, 2H), 5.80 (ddd, J = 17.2, 10.4, 7.6 
Hz, 1H), 5.69 (ddd, J = 17.2, 10.0, 7.2 Hz, 1H), 5.18 (d, J = 12.4 Hz, 1H), 5.15 - 5.04 
(m, 2H), 5.05 - 4.98 (m, 2H), 4.83 (d, J = 6.0 Hz, 1H), 4.14 - 4.09 (m, 2H), 3.24 - 3.18 
(m, 1H), 1.20 (t, J = 6.8 Hz, 3H); 13C NMR (CDCl3, 100MHz) δ 167.8, 161.5, 137.6, 
136.0, 135.6, 128.4, 128.3, 127.0, 118.0, 117.7, 98.7, 86.4, 59.8, 54.2, 14.4; IR 
(NaCl): 3584, 2981, 1731, 1651, 1373 cm–1; HRMS (ESI): m/z [M+Na]+ calcd for 
C17H20O3: 295.1310, found: 295.1293. 
Ethyl (E)-3-hydroxyocta-5,7-dienoate (39). To a solution of 38 (100 mg, 0.37 
mmol) in CH2Cl2 (2.00 mL) under a N2 atmosphere at 0°C was added TFA (0.03 mL, 
0.41 mmol) and the resultant reaction mixture allowed to warm to room temperature 
and stirred overnight. After this period NaHCO3 (2 mL) was added to the reaction 
mixture, the reaction mixture was then transferred to a separating funnel with 
additional CH2Cl2 (20 mL) and water (20 mL), the layers separated, and the aqueous 
layer extracted with a further portion of CH2Cl2 (20 mL). The combined organic 
extracts were then dried (Na2SO4), filtered and the solvent removed under vacuum 
and the crude oil purified by column chromatography (4:1, light petroleum: ethyl 
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acetate, Rf = 0.3) yielding a colourless liquid (56 mg, 0.30 mmol, 82%): 1H NMR 
(CDCl3, 400MHz) δ 6.30 (dt, J = 16.8, 10.4 Hz, 1H), 6.12 (dd, J = 15.2, 10.8 Hz, 1H), 
5.69 (pent, J = 7.2 Hz, 1H), 5.12 (d, J = 16.8 Hz, 1H), 5.00 (d, J = 9.6 Hz, 1H), 4.15 
(q, J = 7.6 Hz, 1H), 4.11 - 4.04 (m, 1H), 2.98 (d, J = 3.6 Hz, 1H), 2.50 (dd, J = 16.8, 
4.0 Hz, 1H), 2.40 (dd, J = 16.4, 8.8 Hz, 1H), 2.36 - 2.23 (m, 2H), 1.25 (t, J = 7.2 Hz, 
3H); 13C NMR (CDCl3, 100MHz) δ 171.9, 136.8, 134.3, 129.7, 116.3, 67.7, 60.8, 
40.7, 39.7, 14.3; IR (NaCl): 3583, 2983, 2253, 1719, 1374 cm–1; HRMS (ESI): m/z 
[M+Na]+ calcd for C10H16O3: 207.0997, found: 207.0983. 
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